tradingkey.logo
tradingkey.logo
Suchen

Autonomix Medical Inc

AMIX
Zur Watchlist hinzufügen
6.430USD
-0.470-6.81%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
3.49MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Autonomix Medical Inc Unternehmen

Autonomix Medical, Inc. is a medical device company focused on advancing technologies to develop how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The Company is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.

Autonomix Medical Inc Informationen

BörsenkürzelAMIX
Name des UnternehmensAutonomix Medical Inc
IPO-datumJan 29, 2024
CEOHauser (Bradley)
Anzahl der mitarbeiter8
WertpapierartOrdinary Share
GeschäftsjahresendeJan 29
Addresse21 Waterway Ave, Suite 300
StadtTHE WOODLANDS
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl77380
Telefon18322777816
Websitehttps://autonomix.com/
BörsenkürzelAMIX
IPO-datumJan 29, 2024
CEOHauser (Bradley)

Führungskräfte von Autonomix Medical Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
4.83K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
1.70K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
740.00
+29.32%
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
179.00
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Jonathan P. Foster
Mr. Jonathan P. Foster
Independent Director
Independent Director
--
--
Ms. Lori H. Bisson
Ms. Lori H. Bisson
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
--
--
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
--
--
Ms. Jenene Thomas
Ms. Jenene Thomas
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
4.83K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
1.70K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
740.00
+29.32%
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
179.00
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Autonomix Medical Inc?

Die fünf größten Anteilseigner von Autonomix Medical Inc sind: Mr. Landy Toth

Wie viele Institutionen halten Anteile an Autonomix Medical Inc (AMIX)?

Mit Stand vom 2026Q1 halten 42 Institutionen Anteile an Autonomix Medical Inc, mit einem Gesamtmarktwert von etwa 319.97K, was 2.80% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -276558.00 gestiegen.